Abstract:Background Ambroxol is a widely used mucoactive drug in sputum clearance of respiratory diseases taken orally and by injection. However, there is a paucity of evidence for inhaled ambroxol in sputum clearance. Methods This study performed a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial at 19 centers in China. Hospitalized adult patients with mucopurulent sputum and expectoration difficulty were recruited. Patients were randomized by 1:1 to receive inhalation of either ambroxol hydrochloride solution 3 mL (22.5 mg) + 0.9% sodium chloride 3 mL or 0.9% sodium chloride 6 mL twice daily for 5 days, with an interval of more than 6 h. The primary efficacy endpoint was the absolute change in the sputum property score after treatment compared to the baseline in the intention-to-treat population. Results Between 10 April 2018 and 23 November 2020, 316 patients were recruited and assessed for eligibility, of whom 138 who received inhaled ambroxol and 134 who received a placebo were included. Patients who received inhaled ambroxol had a significantly greater decrease in the sputum property score compared with patients who received inhalation of placebo (difference: −0.29; 95% CI: −0.53 to −0.05; p = 0.0215). Compared with the placebo, inhaled ambroxol also significantly reduced more expectoration volume in 24 h (difference: −0.18; 95% CI: −0.34 to −0.03; p = 0.0166). There was no significant difference in the proportion of adverse events between the two groups, and no deaths were reported. Discussion In hospitalized adult patients with mucopurulent sputum and expectoration difficulty, inhaled ambroxol was safe and effective for sputum clearance compared with a placebo. Clinical trial registration [ https://www.chictr.org.cn/showproj.html?proj=184677 ], Chinese Clinical Trial Registry [ChiCTR2200066348].

Investigation and Analysis of Ambroxol Use in Our Inpatient Departments

Utilization of ambroxol in inpatients

Analysis of Off-Label Drug Use of Ambroxol Hydrochloride Injections in Hospitalized Elderly Patients

Analysis on Application Rationality of Ambroxol Tablets in 50210 Outpatient Prescriptions from Eye and ENT Hospital of Fudan University

Drug Utilization of Antihypertensives for Outpatients in a General Hospital

Clinical effect of large dose of ambroxol in treatment of acute episode of chronic bronchitis (AECB)

Analysis of Severe Irrational Inpatient Medical Orders Intercepted by an Online Software

Evaluation of Efficacy and Safety of Injective Ambroxol Hydrochloride

Analysis of Medical Orders for Oral Administration of Hospitalized Patients

The Characteristic and Difference of Drugs Use between Outpatients and Inpatients of Pediatrics and Rationality Analysis in a Grade Three Hospital

Indicators of Antibiotics in Outpatient Prescriptions and Irrational Drug Use Analysis

Clinical Study of Inhaled Ambroxol in the Adjunctive Treatment of Lower Respiratory Tract Infection Induced by Pseudomonas Aeruginosa

Use of Drugs in Outpatient Dermatological Department of Our Hospital

Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty

Analysis of antibacterial use with the quota of average treated day in emergency department

A Multicenter Randomized Controlled Clinical Trials of Ambroxol Hydrochloride Injection in Adjuvant Treatment of Respiratory Diseases

Analysis of Oral Sedative Hypnotics in Outpatient Prescriptions of Our Hospital

Aerosol Inhalation of Ambroxol for Pneumonia: A Systematic Review

Analysis of Utilization of Antibacterials in the Outpatient and Emergency Department in 2008

Evaluation of rational drug use for outpatient prescriptions in department of oral and maxillofacial surgery in our hospital

Evaluation of Outpatient Prescriptions and Analysis of Drug Use in Department of Cariology and Endodontology in the Hospital